Promazine hydrochloride

Promazine hydrochloride (CAS No.: 53-60-1) is a synthetic phenothiazine derivative broadly classified as a neuropharmacology research tool compound for central nervous system receptor signaling studies and mechanism based drug discovery workflows, with a functional profile characterized by antagonism at dopaminergic receptors including D1, D2, and D4 subtypes, serotonergic 5 HT2A and 5 HT2C receptors, muscarinic cholinergic M1 through M5 receptors, alpha1 adrenergic receptors, and histamine H1 receptors, thereby supporting its use as a multiparametric modulator of monoaminergic and cholinergic neurotransmission and as a probe for receptor cross talk, network level signal integration, and ligand selectivity analysis in complex assay systems; available literature and class level pharmacology indicate that activity for phenothiazine receptor interactions is commonly observed from nanomolar to micromolar range depending on target subtype, assay platform, and cellular context, while for this specific compound detailed standardized potency datasets may vary across sources, so in vitro interpretation is generally performed using concentration response designs spanning submicromolar to low micromolar levels in receptor binding, second messenger, electrophysiology, or phenotypic assays; in biomedical research it is typically applied in neuronal and non neuronal cell models to dissect dopamine dependent signaling and broader GPCR mediated pathways, and in preclinical animal based pharmacology paradigms to evaluate behavioral and neurochemical endpoints relevant to receptor blockade mechanisms, with experimental concentrations or doses selected according to study design, exposure duration, and endpoint sensitivity, making it suitable for target deconvolution, reference compound benchmarking, and early stage screening panels focused on central receptor pharmacology under strictly non clinical and non consumptive laboratory use conditions.